Re:FDA approves first test of CRISPR for genetic defect caus...
by maxerickson on Wednesday April 07, 2021 @10:51PM
(#26734563)
This treatment modifies the adult hemoglobin gene.
Re:FDA approves first test of CRISPR for genetic defect caus...
by refurb on Thursday April 08, 2021 @10:28PM
(#26746092)
That's what I get for not reading the article. But the point stands on correcting genetics for hematopoetic cells. It's possible to fix a small number of cells, then reimplant (often depleting the cells in the person first) and they will replicate.
Easier than trying to fix the cells in a solid organ.
So you remove bone marrow from the patient, modify the cells, put them back in. The modified cells produce fHb at a high enough level that symptoms of Sickle Cell go away.
Not that different than the already approved CAR-T therapies (with the exception they don't use CRISPR for the genetic modification).